Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease and is characterized by the degeneration of upper and lower motor neurons of the brain and spinal cord. ALS is also linked clinically, genetically, and pathologically to a form of dementia known as frontotemporal dementia (FTD). Identifying gene mutations that cause ALS/FTD has provided valuable insight into the disease process. Several ALS/FTD-causing mutations occur within proteins with roles in protein clearance systems. This includes ALS/FTD mutations in CCNF, which encodes the protein cyclin F: a component of a multiprotein E3 ubiquitin ligase that mediates the ubiquitylation of substrates for their timely degradation. In this review, we provide an update on the link between ALS/FTD CCNF mutations and neurodegeneration.
AraiTHasegawaMAkiyamaHIkedaKNonakaTMoriH, and others. 2006. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun351(3):602–11.
2.
AraiTNonakaTHasegawaMAkiyamaHYoshidaMHashizumeY, and others. 2003. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett342(1–2):41–4.
3.
BaiCRichmanRElledgeSJ. 1994. Human cyclin F. EMBO J13(24):6087–98.
4.
BettJSCookCPetrucelliLBatesGP. 2009. The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington’s disease. PLoS One4(4):e5128.
5.
BoilléeSVande VeldeCClevelandDWW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron52(1):39–59.
6.
BorgoCD’AmoreCSarnoSSalviMRuzzeneM.2021. Protein kinase CK2: a potential therapeutic target for diverse human diseases.Signal Transduct Target Ther6(1):183.
7.
ChengFDe LucaAHoganALRaynerSLDavidsonJMWatchonM, and others. 2021. Unbiased label-free quantitative proteomics of cells expressing amyotrophic lateral sclerosis (ALS) mutations in CCNF reveals activation of the apoptosis pathway: a workflow to screen pathogenic gene mutations. Front Mol Neurosci14:627740.
8.
ChoudhuryRBonacciTArceciALahiriDMillsCAKernanJL, and others. 2016. APC/C and SCFcyclin F constitute a reciprocal feedback circuit controlling S-phase entry. Cell Rep16(12):3359–72.
9.
ChoudhuryRBonacciTWangXTruongAArceciAZhangY, and others. 2017. The E3 ubiquitin ligase SCF(cyclin F) transmits AKT signaling to the cell-cycle machinery. Cell Rep20(13):3212–22.
10.
CiryamPLambert-SmithIABeanDMFreerRCidFTartagliaGG, and others. 2017. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc Natl Acad Sci U S A114(20):E3935–43.
11.
ClijstersLHoencampCCalisJJAMarzioAHandgraafSMCuitinoMC, and others. 2019. Cyclin F controls cell-cycle transcriptional outputs by directing the degradation of the three activator E2Fs. Mol Cell74(6):1264–77.e7.
12.
D’AngiolellaVDonatoVForresterFMJeongYTPellacaniCKudoY, and others. 2012. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell149(5):1023–34.
13.
D’AngiolellaVDonatoVVijayakumarSSarafAFlorensLWashburnMP, and others. 2010. SCF(cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradationNature466(7302):138–42.
14.
DankertJFRonaGClijstersLGeterPSkaarJRBermudez-HernandezK, and others. 2016. Cyclin F–mediated degradation of SLBP limits H2A.X accumulation and apoptosis upon genotoxic stress in G2. Mol Cell64(3):507–19.
15.
DavidsonJMChungRSLeeA.2022. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Neurobiol Dis166:105653.
16.
DeerlinVMVan LeverenzJBBekrisLMBirdDYuanWElmanLB, and others. 2013. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol7(5):409–16.
17.
DeJesus-HernandezMMackenzieIRBoeveBFBoxerALBakerMRutherfordNJ, and others. 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. Neuron72(2):245–56.
18.
DengHXChenWHongSTBoycottKMGorrieGHSiddiqueN, and others. 2011. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature477(7363):211–5.
19.
DengHXZhaiHBigioEHYanJFectoFAjroudK, and others. 2010. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol67(6):739–48.
20.
DengZSheehanPChenSYueZ.2017. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?Mol Neurodegener12(1):90.
21.
DeshmukhRSSharmaSDasS.2018. Cyclin F-dependent degradation of RBPJ inhibits IDH1R132H-mediated tumorigenesis. Cancer Res78(22):6386–98.
22.
DittmarGWinklhoferKF. 2020. Linear ubiquitin chains: cellular functions and strategies for detection and quantification.Front Chem7:915.
23.
EliaAEHBoardmanAPWangDCHuttlinELEverleyRADephoureN, and others. 2015. Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response. Mol Cell59(5):867–81.
24.
EmanueleMJEliaAEHXuQThomaCRIzharLLengY, and others. 2011. Global identification of modular cullin-RING ligase substrates. Cell147(2):459–74.
25.
FargMASooKYWarraichSTSundaramoorthyVBlairIPAtkinJD. 2013. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Hum Mol Genet22(4):717–28.
26.
FectoFYanJVemulaSPLiuEYangYChenW, and others. 2011. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol68(11):1440–6.
27.
FerrariRHernandezDGNallsMARohrerJDRamasamyAKwokJBJ, and others. 2014. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol13(7):686–99.
28.
GalJStrömALKiltyRZhangFZhuH.2007. P62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem282(15):11068–77.
29.
GalperJRaynerSLHoganALFifitaJALeeAChungRS, and others. 2017. Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer. Int J Biochem. Cell Biol89:216–20.
30.
GlickDBarthSMacleodKF. 2010. Autophagy: cellular and molecular mechanisms. J Pathol221(1):3–12.
31.
HebronMLLonskayaISharpeKWeerasinghePPKAlgarzaeNKShekoyanAR, and others. 2013. Parkin ubiquitinates tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J Biol Chem88(6):4103–15.
32.
Hiji MasanoriMTakahashiTFukubaHYamashitaHKohriyamaTMatsumotoM. 2008. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43–immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathol116(2):183–91.
33.
HoganALDonEKRaynerSLLeeALairdASWatchonM, and others. 2017. Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype. Hum Mol Genet28(4):698.
34.
HoganALGrimaNFifitaJAMcCannEPHengBFatSCM, and others. 2021. Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol47(7):990–1003.
35.
HortobágyiTTroakesCNishimuraALVanceCVan SwietenJCSeelaarH, and others. 2011. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol121(4):519–27.
36.
KleinDKHoffmannSAhlskogJKO’HanlonKQuaasMLarsenBD, and others. 2015. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control. Nat Commun6:5800.
37.
KocaturkNMGozuacikD.2018. Crosstalk between mammalian autophagy and the ubiquitin-proteasome system. Front Cell Dev Biol6:5800.
38.
KuusistoESuuronenTSalminenA.2001. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun280(1):223–8.
39.
LeeARaynerSLGweeSSLDe LucaAShahheydariHSundaramoorthyV, and others. 2018. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48–linked ubiquitylation and defective autophagy. Cell Mol Life Sci75(2):335–54.
40.
LeeARaynerSLDe LucaAGweeSSLMorschMSundaramoorthyV, and others. 2017. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48–ubiquitylation E3 ligase activity of the SCF(cyclin F) complex. Open Biol7(10):170058.
41.
LeeYCHuangWCLinJHKaoTJLin Hui ChingLeeKH, and others. 2018. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43–ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology. J Biomed Sci25(1):76.
42.
LeighPNWhitwellHGarofaloOBullerJSwashMMartinJE, and others. 1991. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis: morphology, distribution, and specificity. Brain114 (pt 2):775–88.
43.
LimYWJamesDHuangJLeeM.2020. The emerging role of the RNA-binding protein SFPQ in neuronal function and neurodegeneration. Int J Mol Sci21(19):7151.
44.
LingSCPolymenidouMClevelandDW. 2013. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron79(3):416–38.
45.
LuisierRTyzackGEHallCEMitchellJSDevineHTahaDM, and others. 2018. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat Commun9(1):2010.
46.
McCannEPWilliamsKLFifitaJATarrISO’ConnorJRoweDB, and others. 2017. The genotype–phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet92(3):259–66.
47.
MeyerHWeihlCC. 2014. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci127(pt 18):3877–83.
48.
MillsCAWangXBhattDPGrimsrudPAMatsonJPLahiriD, and others. 2021. Sirtuin 5 is regulated by the SCF cyclin F ubiquitin ligase and is involved in cell cycle control. Mol Cell Biol41(2):e00269-20.
49.
NeumannMSampathuDMKwongLKTruaxACMicsenyiMCChouTT, and others. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science314(5796):130–3.
50.
PanCJiaoBXiaoTHouLZhangWLiuX, and others. 2017. Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from mainland China. Amyotroph Lateral Scler Front Degener18(3–4):265–8.
51.
RameshNPandeyUB. 2017. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front Mol Neurosci10:263.
52.
RaynerSLChengFHoganALGrimaNYangSKeYD, and others. 2021. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. Hum Mol Genet30(11):971–84.
53.
RaynerSLYangSFarrawellNEJagarajCJChengFDavidsonJM, and others. 2022. TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex. Neurobiol Dis167:105673.
54.
RentonAEMajounieEWaiteASimón-SánchezJRollinsonSGibbsJR, and others. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21–linked ALS-FTD. Neuron72(2):257–68.
55.
SeibenhenerMLBabuJRGeethaTWongHCKrishnaNRWootenMW. 2004. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol24(18):8055–68.
56.
ShaZSchnellHMRuoffKGoldbergA.2018. Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation. J Cell Biol217(5):1757–76.
57.
TekchamDSChenDLiuYLingTZhangYChenH, and others. 2020. F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects. Theranostics10(9):4150–67.
58.
TennoTFujiwaraKTochioHIwaiKMoritaEHHayashiH, and others. 2004. Structural basis for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells9(10):865–75.
59.
TianDLiJTangLZhangNFanD.2018. Screening for CCNF mutations in a Chinese amyotrophic lateral sclerosis cohort. Front Aging Neurosci10:185.
60.
TsaiPCLiaoYCChenPLGuoYCChenYHJihKY, and others. 2018. Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis. Neurobiol Aging 62:243.e1–6.
61.
VanceCRogeljBHortobágyiTDe VosKJNishimuraALSreedharanJ, and others. 2009. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science323(5918):1208–11.
62.
WalterDHoffmannSKomseliESRappsilberJGorgoulisVSørensenCS. 2016. SCFCyclin F-dependent degradation of CDC6 suppresses DNA re-replication. Nat Commun7:10530.
63.
WangGYangHYanSWangCELiuXZhaoB, and others. 2015. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain. Mol Neurodegener10:42.
WattsGDJWymerJKovachMJMehtaSGMummSDarvishD, and others. 2004. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet36(4):377–81.
66.
WenqiangCLonskayaIHebronMLIbrahimZOlszewskiRTNealeJH, and others. 2014. Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Hum Mol Genet23(18):4960–9.
67.
WilliamsKLToppSYangSSmithBFifitaJAWarraichST, and others. 2016. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun7:11253.
68.
WilliamsKLWarraichSTYangSSolskiJAFernandoRRouleauGA, and others. 2012. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol Aging33(10):2527.e3–10.
69.
WootenMWHuXBabuJRSeibenhenerMLGeethaTPaineMG, and others. 2006. Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62’s role in neurodegenerative disease. J Biomed Biotechnol2006:62079.
70.
YuYNakagawaTMorohoshiANakagawaMIshidaNSuzukiN, and others. 2019. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of cyclin F and elevated VCP ATPase activity. Hum Mol Genet28(20):3486–97.
71.
YuanRLiuQSegerenHAYuniatiLGuardavaccaroDLebbinkRJ, and others. 2019. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression. EMBO J38(20):e101430.
